Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

Skin conditions, diet choices, and some chronic health conditions may make the bottom of your feet yellow. Treating the cause ...

New York-Presbyterian filed plans Thursday to construct a new oncology infusion suite at its Queens hospital, becoming the ...

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Ascentage Pharma Group International (($HK:6855)) announced an update on their ongoing clinical study. Study Overview: Ascentage Pharma Group Inc.

Disc Medicine, Inc. (($IRON)) announced an update on their ongoing clinical study. Disc Medicine, Inc. is conducting a study titled RALLY-MF: A ...

Her treatment plan, including transfusions and medication ... Doctors diagnosed Davis with warm autoimmune hemolytic anemia, ...

Pharmacists in the ACT will be able to treat for additional conditions and provide vaccinations for children as young as two, under an expanded program from early 2026. The expansion follows a pilot ...

LONDON, Oct 15 (Reuters) - German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million ...

Hims & Hers Health HIMS-1.04%decrease; red down pointing triangle said it is now providing menopause care, marking the company’s latest push into hormone-replacement therapies. The telehealth company ...